101 related articles for article (PubMed ID: 3910768)
21. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
[TBL] [Abstract][Full Text] [Related]
22. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
23. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
24. Anti-hypertensive effects of intravenous compared with oral captopril.
Sramek JJ; Brennan JJ; Much DR; Duchin K; Luna A; Cutler NR
J Hum Hypertens; 1995 Nov; 9(11):875-8. PubMed ID: 8583465
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of the efficacy of enalapril + hydrochlorothiazide and captopril + hydrochlorothiazide combinations in mild-to-moderate arterial hypertension by ambulatory measurement of blood pressure].
Mayaudon H; Chanudet X; Janin G; Madonna O
Ann Cardiol Angeiol (Paris); 1995 May; 44(5):235-41. PubMed ID: 7639505
[TBL] [Abstract][Full Text] [Related]
26. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the efficacy and safety of trandolapril and captopril for 16 weeks in mild-to-moderate essential hypertension. Investigator Study Group.
Pauly NC; Safar ME
J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S73-6. PubMed ID: 7527106
[TBL] [Abstract][Full Text] [Related]
28. Review of studies on the clinical pharmacodynamics of cilazapril.
Belz GG; Breithaupt K; Erb K
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S14-9. PubMed ID: 7898090
[TBL] [Abstract][Full Text] [Related]
29. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
30. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
[TBL] [Abstract][Full Text] [Related]
31. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
32. Influence of food on acute and chronic effects of captopril in essential hypertensive patients.
Salvetti A; Pedrinelli R; Magagna A; Abdel-Haq B; Graziadei L; Taddei S; Stornello M
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S25-9. PubMed ID: 2580172
[TBL] [Abstract][Full Text] [Related]
33. Naloxone does not modify the antihypertensive effect of captopril in essential hypertensive patients.
Bernini G; Taddei S; Graziadei L; Pedrinelli R; Salvetti A
J Hypertens Suppl; 1985 Nov; 3(2):S117-9. PubMed ID: 3003298
[TBL] [Abstract][Full Text] [Related]
34. [The efficacy of the captopril treatment of elderly hypertension patients].
Korkushko OV; Fedirko MI; Gidzinskaia IN
Vrach Delo; 1990 Feb; (2):10-3. PubMed ID: 2187303
[TBL] [Abstract][Full Text] [Related]
35. [Plasma leucine enkephalin and beta-endorphin levels in patients with essential hypertension and the effects of captopril].
Gao Y
Zhonghua Yi Xue Za Zhi; 1990 Jun; 70(6):327-9, 24. PubMed ID: 2169983
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake.
Ohman KP; Kågedal B; Larsson R; Karlberg BE
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S20-4. PubMed ID: 2580171
[TBL] [Abstract][Full Text] [Related]
37. Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension.
Luque M; Martin P; Martell N; Fernandez C; Brosnihan KB; Ferrario CM
J Hypertens; 1996 Jun; 14(6):799-805. PubMed ID: 8793704
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the cardiac and peripheral vascular effects of the administration of single-dose enalapril and captopril in essential arterial hypertension].
Longhini C; Ansani L; Musacci GF; Vaccari M; Fraccaroli GP; Mele D; Aggio S; Baracca E
Cardiologia; 1989 Jan; 34(1):61-7. PubMed ID: 2541907
[TBL] [Abstract][Full Text] [Related]
39. Acute captopril treatment in elderly hypertensive patients: a controlled study.
Di Veroli C; Pastorelli R
J Hypertens Suppl; 1988 Nov; 6(1):S95-6. PubMed ID: 3063798
[TBL] [Abstract][Full Text] [Related]
40. Influence of food on the clinical effect of angiotensin I converting enzyme inhibitor (SQ 14,225).
Izumi Y; Honda M; Hatano M; Kawahara Y
Tohoku J Exp Med; 1983 Mar; 139(3):279-86. PubMed ID: 6304936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
